0001225208-15-000098.txt : 20150102
0001225208-15-000098.hdr.sgml : 20150102
20150102164928
ACCESSION NUMBER: 0001225208-15-000098
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150101
FILED AS OF DATE: 20150102
DATE AS OF CHANGE: 20150102
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP
CENTRAL INDEX KEY: 0000885725
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 042695240
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300 BOSTON SCIENTIFIC WAY
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752-1234
BUSINESS PHONE: 508-683-4000
MAIL ADDRESS:
STREET 1: 300 BOSTON SCIENTIFIC WAY
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752-1234
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Nanavaty Maulik
CENTRAL INDEX KEY: 0001529708
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-11083
FILM NUMBER: 15501858
MAIL ADDRESS:
STREET 1: BOSTON SCIENTIFIC CORPORATION
STREET 2: 300 BOSTON SCIENTIFIC WAY
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752-1234
4
1
doc4.xml
X0306
4
2015-01-01
0000885725
BOSTON SCIENTIFIC CORP
BSX
0001529708
Nanavaty Maulik
300 BOSTON SCIENTIFIC WAY
MARLBOROUGH
MA
01752-1234
1
SVP & Pres, Neuromodulation
Common Stock
2015-01-01
4
M
0
15525.0000
0.0000
A
118707.0000
D
Common Stock
2015-01-01
4
F
0
6251.0000
13.2500
D
112456.0000
D
Performance Share Units
2015-01-01
4
M
0
15525.0000
0.0000
D
2014-12-31
2014-12-31
Common Stock
15525.0000
0.0000
D
On February 27, 2012, the reporting person was awarded a target number of performance share units under the Company's 2012 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person based on the Company's 2012 adjusted free cash flow measured against its 2012 financial plan over the one-year performance period ending December 31, 2012 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 28, 2013, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined vested in whole upon the completion of the individual service period that ended on December 31, 2014.
Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.
Each performance share unit represented the Company's commitment to issue one share of Boston Scientific common stock.
/s/ Lee G. Giguere, Attorney-in-Fact
2015-01-02